Category: Observations
-
When Partnership Is Critical, the Team Makes the Difference
What the Spanish diagnostics market shows about competing through complex solutions In complex healthcare markets, the best product is increasingly not enough. Customers are being asked to deliver more clinical value with constrained people and budgets, and the solutions they need now combine technology, workflow, service, supply, integration — and, often, capabilities that sit across…
-
The Triumph of Specialists
This year (at ADLM) I had the chance to verify a old thesis about the role of Specialists in the expansion of diagnostics. Spot on! It came from looking at the market. Put all the specialist areas of diagnostics together and they add up to a remarkable part of the industry. Yet the story we…
-
A Land of Opportunity
Most of us grew up with the idea of America as the land of opportunity — a place where hard work could build a better future. I have arrived in Anaheim in something of that spirit. Next to Disney’s wonderland, I am more interested in the other one down the road. ADLM is a conference…
-
Merck Future Insight Prize 2026, Darmstadt
From “Hearing the Light” to Preventive Health Understanding The 2026 Merck Future Insight Prize focused on a provocative proposition: future healthcare may depend increasingly on the ability to observe biological change before symptoms, deterioration or clinical crisis make it visible. The prize was awarded to Professor Vasilis Ntziachristos for his pioneering work in optoacoustics, an…
-
5 Signals from HLTH Europe That Reveal Diagnostics’ Next Challenge
I attended HLTH Europe looking for signals about the future role of diagnostics in healthcare. AI dominated the agenda, but the most interesting observation was not AI itself. It was the convergence of five themes: Taken together, these conversations point to something larger than technology. Health intelligence is being built. Diagnostics is already part of…
-
Healthcare as Seen at HLTH Europe 2026
This Observation draws on HLTH Europe 2026 as a selective but useful view of where healthcare attention is moving. No conference represents the full reality of healthcare. Conferences highlight certain themes, attract particular audiences, and leave much of everyday clinical, operational, and institutional life outside the room. Even so, they can reveal where investment is…
-
HLTH Europe 2026 – Amsterdam
Is Diagnostics at the Table? HLTH Europe 2026 offers a useful test of diagnostics’ position within the wider transformation of healthcare. The programme is built around many of the questions currently shaping care delivery: artificial intelligence, interoperability, health-data infrastructure, prevention, evidence generation, clinical implementation, and the redesign of patient pathways. Diagnostics is indispensable to each…
-
MedTech Forum 2026 – Stockholm
When Competitiveness Became the Main Signal The MedTech Forum 2026 produced an unusually clear signal. Across three days of sessions and professional exchanges in Stockholm, discussions repeatedly returned to a concern extending beyond regulation alone: whether Europe can maintain the industrial conditions required to convert medical innovation into sustainable scale. MDR and IVDR remained important,…
-
ESCMID Global 2026 Munich – When Diagnostics Became Infrastructure
ESCMID Global 2026 offered a clear view of how diagnostics is changing within infectious-disease management. Across five days in Munich, clinicians, microbiologists, researchers, public-health specialists, and industry participants gathered around an extensive scientific programme covering antimicrobial resistance, antibiotics, vaccines, surveillance, emerging pathogens, infection prevention, clinical microbiology, and the broader management of infectious diseases. Diagnostics did…
-
Analytica 2026 Munich – When Diagnostics Became Infrastructure
Where Analytical Power Meets the Diagnostics Moat analytica 2026 offered a useful vantage point from which to observe technologies before they become diagnostics. Across the exhibition halls in Munich, analytical capability was visible in many forms: proteomics platforms, mass spectrometry in multiple configurations, sequencing automation, flexible pre-analytical robotics, increasingly sophisticated assay workflows, and a broad…